Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Treating the Female Patient with IBD
• 7 Recent Developments in Colonoscopy
• Managing Esophageal Cancer Via Nonsurgical Methods Robin B. Mendelsohn, MD; Christopher J. DiMaio, MD
• Clinical Trial Underway for Microbiome-Based Therapy for IBS-C
• FDA Approves Daklinza for Chronic Hepatitis C Genotype 3 Infections
• FDA Approves Technivie for HCV Genotype 4
• Intercept Files New Drug Application With FDA for Obeticholic Acid
• Personalizing IBD Care: Caring for Women Through Life Changes
• Changing Perspectives on HCV: What Gastroenterologists Need to Know
• Experts Release GI Symptom Management Guidelines for Children With Autism
• FDA Issues Draft Guidance on Clinical Evaluation of Gastroparesis Drugs
• Crohn’s Costs in ‘Era of Biologics’ Higher Than Expected
• Curcumin Shows Promise for Treatment of Mild-to-Moderate Ulcerative Colitis
• FMT Induces Remission in Active Ulcerative Colitis
• H. pylori Eradication may Reduce Gastric Cancer Incidence
• Novel Aciduric Gluten-degrading Enzyme Promising in Celiac Disease
• Pinaverium Safely Reduces IBS Symptoms
• Study Identifies Childhood Immunological, Hygiene, Dietary Risk Factors for IBD in Asia-Pacific
• Uninvestigated Dyspepsia Common, Global Prevalence Varies
• Second-line Cetuximab Plus FOLFOX Extends PFS in Wild-type Metastatic Colorectal Cancer
• Study Confirms Regorafenib Benefit for Previously Treated Metastatic Colorectal Cancer
• $1.9 Million NIH Grant Supports Nonantibiotic Therapy for C. difficile
• ASGE, ACG, AGA Oppose Cuts to Colonoscopy Reimbursement Rates
• ESPGHAN: More Research Needed on Use of Biosimilars in Pediatric IBD
• FDA Sued by Public Health Groups Over Sovaldi, Harvoni